Ardelyx’s (ARDX) Neutral Rating Reiterated at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a $5.50 price target on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Ardelyx’s FY2029 earnings at $1.18 EPS. A number of other brokerages […]
HC Wainwright reiterated their neutral rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a $5.50 price target on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Ardelyx’s FY2029 earnings at $1.18 EPS. A number of other brokerages […]
